Scott D. Mosser
About
Scott D. Mosser is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health.
According to data from OpenAlex, Scott D. Mosser has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 15 papers in Psychiatry and Mental health. Recurrent topics in Scott D. Mosser's work include Migraine and Headache Studies (15 papers), Protein Kinase Regulation and GTPase Signaling (12 papers) and Neuropeptides and Animal Physiology (11 papers). Scott D. Mosser is often cited by papers focused on Migraine and Headache Studies (15 papers), Protein Kinase Regulation and GTPase Signaling (12 papers) and Neuropeptides and Animal Physiology (11 papers). Scott D. Mosser collaborates with scholars based in United States, Poland and Italy. Scott D. Mosser's co-authors include W. Wayt Gibbs, Samuel Graham, Allen Oliff, Nancy E. Kohl, Elizabeth A. Giuliani, S. J. DESOLMS, David L. Pompliano, Elaine Rands, Michael D. Schaber and Robert L. Smith and has published in prestigious journals such as Science, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.
In The Last Decade
Scott D. Mosser
39 papers receiving 1.9k citations
Peers
Scott D. Mosser
Flora Tang United States
Qi-Huang Zheng United States
Tjeerd Barf Netherlands
Jen‐Shin Song Taiwan
Yichin Liu United States
Lenka Munoz Australia
Steven J. McClue United Kingdom
Mark E. Duggan United States
Mingzhang Gao United States
Robert L. Hudkins United States
Citations per year, relative to Scott D. Mosser Scott D. Mosser (= 1×)
peers
Flora Tang
Countries citing papers authored by Scott D. Mosser
Since
Specialization
Citations
This map shows the geographic impact of Scott D. Mosser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Mosser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Mosser more than expected).
Fields of papers citing papers by Scott D. Mosser
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Scott D. Mosser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Mosser. The network helps show where Scott D. Mosser may publish in the future.
Co-authorship network of co-authors of Scott D. Mosser
This figure shows the co-authorship network connecting the top 25 collaborators of Scott D. Mosser. A scholar is included among the top collaborators of Scott D. Mosser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott D. Mosser. Scott D. Mosser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bell, Ian M., Craig A. Stump, Steven N. Gallicchio, et al.. (2012). MK-8825: A potent and selective CGRP receptor antagonist with good oral activity in rats. Bioorganic & Medicinal Chemistry Letters. 22(12). 3941–3945.
2.
Burgey, Christopher S., James Z. Deng, Scott D. Mosser, et al.. (2009). Optimization of azepanone calcitonin gene-related peptide (CGRP) receptor antagonists: Development of novel spiropiperidines. Bioorganic & Medicinal Chemistry Letters. 19(22). 6368–6372.
3.
McIntyre, Charles, John A. McCauley, Bohumil Bednář, et al.. (2009). Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 5132–5135.
4.
Bell, Ian M., Rodney A. Bednar, John F. Fay, et al.. (2009). The identification of potent, orally bioavailable tricyclic CGRP receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(16). 4740–4742.
5.
Wood, Michael R., Craig A. Stump, Ian M. Bell, et al.. (2009). Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibility. Bioorganic & Medicinal Chemistry Letters. 19(19). 5787–5790.
6.
Theberge, Cory R., Rodney A. Bednar, Ian M. Bell, et al.. (2008). Potent benzimidazolone-based CGRP receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(23). 6122–6125.
7.
Paone, Daniel V., Anthony W. Shaw, Diem N. Nguyen, et al.. (2007). Potent, Orally Bioavailable Calcitonin Gene-Related Peptide Receptor Antagonists for the Treatment of Migraine: Discovery of N -[(3 R ,6 S )-6-(2,3-Difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1 H -imidazo[4,5- b ]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974). Journal of Medicinal Chemistry. 50(23). 5564–5567.
8.
Nguyen, Kevin T., Christopher F. Claiborne, John A. McCauley, et al.. (2007). Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(14). 3997–4000.
9.
Salvatore, Christopher, James C. Hershey, John F. Fay, et al.. (2007). Pharmacological Characterization of MK-0974 [N-[(3 R,6 S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1 H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine. Journal of Pharmacology and Experimental Therapeutics. 324(2). 416–421.
10.
Williams, Theresa M., Craig A. Stump, Diem N. Nguyen, et al.. (2006). Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead. Bioorganic & Medicinal Chemistry Letters. 16(10). 2595–2598.
11.
Dinsmore, Christopher J., C. Blair Zartman, Jeffrey M. Bergman, et al.. (2004). Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 14(3). 639–643.
12.
Hershey, James C., Elizabeth Baskin, Christopher Salvatore, et al.. (2004). Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay. Regulatory Peptides. 127(1-3). 71–77.
13.
Buser, Carolyn A., Christopher J. Dinsmore, Christine Fernandes, et al.. (2001). High-Performance Liquid Chromatography/Mass Spectrometry Characterization of Ki4B-Ras in PSN-1 Cells Treated with the Prenyltransferase Inhibitor L-778,123. Analytical Biochemistry. 290(1). 126–137.
14.
Subler, Mark A., Elaine Rands, Charles A. Omer, et al.. (1998). A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis. Molecular and Cellular Biology. 18(1). 85–92.
15.
Breslin, Michael J., S. J. DESOLMS, Elizabeth A. Giuliani, et al.. (1998). Potent, non-thiol inhibitors of farnesyltransferase. Bioorganic & Medicinal Chemistry Letters. 8(23). 3311–3316.
16.
Wallace, Andrew, Kenneth S. Koblan, Kelly Hamilton, et al.. (1996). Selection of Potent Inhibitors of Farnesyl-protein Transferase from a Synthetic Tetrapeptide Combinatorial Library. Journal of Biological Chemistry. 271(49). 31306–31311.
17.
Kohl, Nancy E., et al.. (1995). [38] Inhibition of Ras function in Vitro and in Vivo using inhibitors of farnesyl-protein transferase. Methods in enzymology on CD-ROM/Methods in enzymology. 255. 378–386.
18.
Wai, John, Thorsten E. Fisher, Samuel Graham, et al.. (1994). Synthesis and biological activity of ras farnesyl protein transferase inhibitors. Tetrapeptide analogs with amino methyl and carbon linkages. Bioorganic & Medicinal Chemistry. 2(9). 939–947.
19.
Graham, Samuel, S. J. DESOLMS, Elizabeth A. Giuliani, et al.. (1994). Pseudopeptide Inhibitors of Ras Farnesyl-Protein Transferase. Journal of Medicinal Chemistry. 37(6). 725–732.
20.
Marshall, Mark S., Lenora J. Davis, Robert D. Keys, et al.. (1991). Identification of Amino Acid Residues Required for Ras p21 Target Activation. Molecular and Cellular Biology. 11(8). 3997–4004.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Flora Tang Breakdown of academic impact, for papers by Qi-Huang Zheng Breakdown of academic impact, for papers by Tjeerd Barf Breakdown of academic impact, for papers by Jen‐Shin Song Breakdown of academic impact, for papers by Yichin Liu Breakdown of academic impact, for papers by Lenka Munoz Breakdown of academic impact, for papers by Steven J. McClue Breakdown of academic impact, for papers by Mark E. Duggan Breakdown of academic impact, for papers by Mingzhang Gao Breakdown of academic impact, for papers by Robert L. Hudkins